Panasonic Healthcare Holdings €1.022 billion acquisition of Diabetes Care (Ascensia)

1/1/2016
Private acquisition

€ 1.022 billion

$ 1.15 billion

Completed

1/1/2016


Overview:

  • Panasonic Healthcare Holdings has acquired Diabetes Care for €1.022 billion from Bayer.
  • The acquirer is 80% owned by US fund Kohlberg Kravis Roberts & Co (KKR), with Panasonic holding the other 20%.
  • Diabetes Care has been rebranded as Ascensia since the sale. 
  • Bayer's sale of the unit is part of its strategy to raise cash to make investments in crop protection, healthcare and veterinary products. 

Ben Naylor - Regional Editor

Jurisdictions:

Canada
United States
Japan
Germany

Deal type:

Private acquisition

Practice areas:

Private equity
M&A

Industry sector:

Healthcare